Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 2.840
+0.090 (3.27%)
At close: Mar 27, 2026
Clover Biopharmaceuticals Employees
Clover Biopharmaceuticals had 243 employees as of June 30, 2025. The number of employees decreased by 57 or -19.00% since the number was reported on December 31, 2024.
Employees
243
Change
-57
Growth
-19.00%
Revenue / Employee
16.05K HKD
Profits / Employee
-939.21K HKD
Market Cap
3.69B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 243 | -57 | -19.00% |
| Dec 31, 2024 | 300 | -87 | -22.48% |
| Dec 31, 2023 | 387 | -377 | -49.35% |
| Dec 31, 2022 | 764 | -50 | -6.14% |
| Dec 31, 2021 | 814 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Viva Biotech Holdings | 2,063 |
| AIM Vaccine | 1,493 |
| Shandong Boan Biotechnology | 714 |
| BioDlink International Company | 604 |
| Jiangsu Recbio Technology | 507 |
| Mirxes Holding Company | 347 |
| Qyuns Therapeutics | 337 |
| Beijing Luzhu Biotechnology | 197 |
Clover Biopharmaceuticals News
- 3 days ago - Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV Re-Vaccination In Older Adults - Nasdaq